Patient | Age | Gender | Smoking | Location | Stage | Presentation | Treatment | Survival (months) |
---|---|---|---|---|---|---|---|---|
1 [6] | 83 | M | N/A | Upper | IVA | Dysphagia | Palliative | < 2 |
2 [7] | 58 | M | N/A | Lower | IIB | Dysphagia | Adjuvant cisplatin + etoposide | > 36 |
3 [8] | 73 | M | Current | Lower | IVB | Dysphagia | Adjuvant docetaxel + fluorouracil | 20 |
4 [9] | 51 | M | Never | Lower | IA | Dysphagia | Adjuvant chemoradiotherapy | N/A |
5 [10] | 55 | M | N/A | Lower | IVB | Abdominal pain | Palliative | 1 |
6 [11] | 81 | M | N/A | Lower | Weight loss | Surgery | > 18 | |
7 [12] | 66 | F | Never | Mid | IVB | Dysphagia | N/A | N/A |
8 [13] | 81 | M | N/A | Mid | Dysphagia | Adjuvant chemoradiation | 8 | |
9 [14] | 75 | F | N/A | Lower | IIA | N/A | Adjuvant irinotecan + cisplatin + radiotherapy | 13 |
10 [14] | 60 | M | N/A | Mid-lower | IIIB | N/A | Adjuvant irinotecan + cisplatin | 13 |
11 [14] | 69 | M | N/A | Lower | IIIB | N/A | Neoadjuvant irinotecan + cisplatin + radiotherapy | 18 |
12 [15] | 43 | M | Never | Lower | IVB | Abdominal pain | Fluorouracil + cisplatin | 11 |
13 [16] | 85 | F | Second-hand smoking | Mid | IVA | Dysphagia | Palliative | 1 |
14 [17] | 65 | M | N/A | Lower | IVA | Heartburn | Adjuvant chemotherapy | 9 |